BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15172230)

  • 1. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
    Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
    Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
    Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
    Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
    Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
    Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.
    Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; CalabrĂ² F; Casali C; Marulli G; Spaggiari L
    Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprint cytologic features of pulmonary large cell neuroendocrine carcinoma: Comparison with classic large cell carcinoma.
    Iyoda A; Baba M; Hiroshima K; Saitoh H; Moriya Y; Shibuya K; Iizasa T; Horiuchi F; Ohwada H; Fujisawa T
    Oncol Rep; 2004 Feb; 11(2):285-8. PubMed ID: 14719055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
    Jiang SX; Kameya T; Shinada J; Yoshimura H
    Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung.
    Marmor S; Koren R; Halpern M; Herbert M; Rath-Wolfson L
    Diagn Cytopathol; 2005 Oct; 33(4):238-43. PubMed ID: 16138368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
    Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
    Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
    Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
    Zhao P; Hou N; Shao Y; Li XH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
    Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
    Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.